The Latest RoboSense LiDAR Perception Solution Will Support Robo Taxi Development
4.12.2019 17:00:00 EET | Business Wire | Press release
RoboSense today announced its launch of a developed and complete LiDAR perception solution for Robo Taxi (RS-Fusion-P5) in markets outside China. The RS-Fusion-P5 was first launched in China last month. Equipped with an RS-Ruby and four RS-BPearl, The RS-Fusion-P5 is considered to be the alternative to Waymo's LiDAR solution, further accelerating the development of Robo Taxi.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191204005271/en/
(Graphic: Business Wire)
Full Coverage, Zero Blind Spots In The Range Of 200 Meters
RoboSense RS-Fusion-P5 uses an RS-Ruby on top of the vehicle to ensure a sensing range with a radius of more than 200 meters. However, even if the vertical field of view (FOV) of RS-Ruby reaches the perfect angles from -25° to +15°, there is still a small blind zone around the vehicle body. Therefore, to cover the small blind zone, 4 RS-BPearl embedded sideways around the vehicle form a hemisphere FOV scanning area relative to the vehicle's perspective, to guarantee a complete 360° surrounding view.
Empowers Level 4 Or Above Autonomous Vehicles With Full-stack Perception Capabilities
The RS-Fusion-P5 solution fuses point clouds from RS-Ruby and RS-BPearl in real-time, and generate laser points of more than 4,600,000pts per second.
Through its advanced AI perception algorithms, multi-sensor fusion and synchronization interfaces, vehicles are able to identify all-around obstacles and position easily and precisely.
The Main RS-Ruby With 0.1 ° Vertical Resolution, 200m @ 10% Ranging Ability
RS-Ruby achieves the anti-interference of multiple LiDAR using special laser encryption technology to filter interference signals. Meanwhile, it is not affected by the strongest direct-sunlight. Its LiDAR reflection intensity reaches a perfect balance of consistency and distinction.
RS-BPearl Reaches The Minimum Detection Range Of Less Than 5cm
The embedded four RS-BPearl form a hemispherical FOV coverage of 90 ° * 360 °, which not only can precisely identify objects around the vehicle body such as pets, children, roadbeds as well as other details of the near-field ground area, but also detect the actual height information under particular scenarios such as bridge tunnels and culverts, further supporting autonomous vehicles for driving decision making and greatly improving car safety.
The RS-Fusion-P5 is able to reach 200m detection range, 0.1° high-precision resolution with full coverage, zero blind spots in the sensing zone. It is one of the leading and developed automotive LiDAR solution for Robo Taxi available on the market. More details of RS-Fusion-P5 can be found at http://www.robosense.cn/rslidar/rs-fusion-p5.
Meanwhile, RoboSense wins CES 2020 Innovation Award for autonomous vehicle technology, and will be exhibiting at booth 6138, LVCC North Hall, CES 2020 from Jan. 7 – 10, 2020, and tabletop No. 602 at CES Unveiled Las Vegas, on Jan. 5, 2020, 5 – 8:30 p.m. PST.
About RoboSense:
The world’s leading autonomous driving LiDAR perception solution provider, RoboSense, supplies LiDAR technologies to a wide range of domestic and international autonomous driving technology companies, OEMs, and tier 1 suppliers. RoboSense technologies are widely used in autonomous driving logistics vehicles, buses, and passenger cars, with partners including SAIC, BAIC, Baidu, Cainiao Network, JD.com, ControlWorks, Aidrivers, and more. In China, RoboSense has received more than 300 million RMB in strategic investments from Alibaba’s Cainiao Network, SAIC, and BAIC, making RoboSense Asia’s number one LiDAR company, with the largest funding in China’s LiDAR industry. RoboSense has won numerous international awards, including the CES 2020 and 2019 Innovation Awards, the 2019 AutoSens Award, and the 2019 Stevie Award - Gold Award. For more information on RoboSense, see the website at http://www.robosense.ai.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191204005271/en/
Contact information
Media:
Cassie Gong
RoboSense PR Manager
sqgong@robosense.cn
86-18620031448
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
KATE Launches "KABUKE: Break Convention" Kabuki-Inspired International Campaign17.7.2026 10:00:00 EEST | Press release
Global cosmetics brand KATE launched “KABUKE: Break Convention,” a new international campaign drawing on elements of Kabuki, the traditional Japanese performing art. The campaign debuted on Wednesday, July 8, 2026. In this campaign, KATE’s shadow enhancing makeup—rooted in Japanese aesthetics—was paired with the Kabuki spirit inherited from traditional Kabuki theater to communicate the value of individuality and self‑expression through makeup on a global scale. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708829427/en/ KATE international campaign “KABUKE: Break Convention” key visual. Dedicated website: https://www.kate-global.net/my/special/kate_kabuki/ Since its founding, KATE has championed the slogan “NO MORE RULES.,” offering makeup that defies convention and empowers individuals to express their identity and bring out confidence. At the heart of this vision is the brand’s signature shadow enhancing makeup approach
Yoshihiro Shimamura Joins the Marché du Film’s “Investors Circle 2026” as an Invited Investor, Backing a New Feature Film17.7.2026 04:00:00 EEST | Press release
Shimamura Yoshihiro Film Production Co., Ltd. (Head office: Osaka, Japan; Representative Director: Yoshihiro Shimamura), a company active in film production and investment, today announced that Representative Director Yoshihiro Shimamura has decided to invest in an international feature film after being invited to the “Investors Circle 2026” — a distinction that reflects his standing as one of the field’s most highly regarded producers and investors. Hosted by the Marché du Film, the business arm of the Festival de Cannes and one of the world’s largest film markets, the Investors Circle is an invitation-only summit that connects a select group of private investors with high-end feature films during early-stage financing. Held in Cannes, France, May 16-17, 2026, it brings internationally acclaimed directors and producers together with investors around a curated slate of projects in development. During the summit, Shimamura attended private pitching sessions and, after individual meeting
Meiji Seika Pharma: Results from the Global Phase III Trial (Integral-2) of Nacubactam, a Novel β-Lactamase Inhibitor, Highlighted in The Lancet Microbe ’s Coverage of ESCMID Global Congress 202617.7.2026 04:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that results from the global Phase III trial (Integral-2) of nacubactam (Development Code: OP0595), a novel β-lactamase inhibitor, were highlighted in The Lancet Microbe’s coverage of ESCMID Global Congress 2026 (held in Munich, Germany). As highlighted in The Lancet Microbe’s coverage, the key findings presented by Meiji Seika Pharma at ESCMID Global Congress 2026 are as follows: The Integral-2 study (jRCT2031230076) is a global Phase III clinical trial that enrolled patients with complicated urinary tract infections, acute uncomplicated pyelonephritis, hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia, or complicated intra-abdominal infections caused by carbapenem-resistant Gram-negative bacteria (excluding Acinetobacter species). The study has achieved the prespecified study objectives. For the primary endpoint of overall treatme
Takeda’s Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies17.7.2026 01:00:00 EEST | Press release
Takeda (TSE:4502/NYSE:TAK) announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279), a next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented at the 2026 American Academy of Dermatology (AAD) Innovation Academy, these secondary endpoint data show that zasocitinib demonstrated consistent and high rates of skin clearance across hard-to-treat, high-impact sites, including the scalp, nails, palms and soles, compared with placebo.1-5 These data build on the topline results from the Phase 3 randomized, multicenter, double-blind, placebo- and active comparator-controlled LATITUDE PsO 3001 and 3002 studies.2,6 In those studies, about 70% of patients treated with zasocitinib achieved static Physician Global Assessment (sPGA) 0/1 (clear or almost clear skin) at week 16, with a significantly greater Psoriasis Area and Severity Index (PASI) 75 response rate seen as early as w
Merz Completes Inaugural €450 Million Schuldschein Loan Issuance17.7.2026 00:36:00 EEST | Press release
The Merz Group has successfully completed its first-ever Schuldschein loan issuance, placing a total volume of €450 million in the debt capital market – a multiple of three relating to the launch volume. The debut transaction was significantly oversubscribed and attracted strong interest from all investor groups. The proceeds were settled and paid out today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260716926041/en/ Dr. Almuth Steinkühler, Chief Financial Officer Merz Group The transaction comprises both fixed- and floating-rate tranches with maturities of three, five, seven, and ten years. Around 50 German and international investors participated, representing a broad range of institutions, including private banks, German federal state-owned banks, public savings banks, cooperative banks, pension funds and occupational pension institutions. With the successful placement, Merz has further diversified its funding base by
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom